2013
DOI: 10.1016/j.canlet.2012.11.046
|View full text |Cite
|
Sign up to set email alerts
|

Aldehyde dehydrogenase 1, a functional marker for identifying cancer stem cells in human nasopharyngeal carcinoma

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

3
51
0
1

Year Published

2014
2014
2018
2018

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 71 publications
(55 citation statements)
references
References 40 publications
3
51
0
1
Order By: Relevance
“…ALDH1 is an intracellular enzyme that oxidizes several kinds of aldehyde to carboxylic acid and shows strong activity in hematopoietic progenitor cells (Kastan et al 1990;Vasiliou et al 2004). In solid tumors, ALDH1 expression has been reported to be a poor prognostic factor in patients with rectal cancer, breast cancer, ovarian cancer, and nasopharyngeal cancer (Ginestier et al 2007;Huang et al 2009;Liu et al 2013;Wu et al 2013;Zhou et al 2010). Among seven putative CSLC markers examined in this study, a multivariate analysis showed that the positive expression of ALDH1 was significantly associated with unfavorable recurrence-free and overall survival after surgical resection of HGNEC.…”
Section: Discussionmentioning
confidence: 97%
See 1 more Smart Citation
“…ALDH1 is an intracellular enzyme that oxidizes several kinds of aldehyde to carboxylic acid and shows strong activity in hematopoietic progenitor cells (Kastan et al 1990;Vasiliou et al 2004). In solid tumors, ALDH1 expression has been reported to be a poor prognostic factor in patients with rectal cancer, breast cancer, ovarian cancer, and nasopharyngeal cancer (Ginestier et al 2007;Huang et al 2009;Liu et al 2013;Wu et al 2013;Zhou et al 2010). Among seven putative CSLC markers examined in this study, a multivariate analysis showed that the positive expression of ALDH1 was significantly associated with unfavorable recurrence-free and overall survival after surgical resection of HGNEC.…”
Section: Discussionmentioning
confidence: 97%
“…To achieve a cure, these tumorigenic stem-like cells must be effectively targeted (Reya et al 2001). Studies have recently been conducted in several solid tumors to identify CSLCs as therapeutic targets, based on strategies that identify possible CSLCs using specific CSLC markers (Al-Hajj et al 2003;Huang et al 2009;Wu et al 2013).…”
Section: Introductionmentioning
confidence: 99%
“…We hypothesize that culturing the SP and NSP cells in complete medium after sorting may have caused the SP cells to differentiate, subsequently losing their stem cell properties. Previous studies have revealed that normal and neoplastic stem cells obtained from neural and epithelial organs only exhibit initial tumor-specific properties when cultured in serum-free medium containing epidermal growth factor (EGF) and fibroblast growth factor (FGF)-2 (33)(34)(35). In addition, adherent cells expanded in Laminin-coated culture plates in serum free medium containing N2-supplement, EGF and basic FGF maintain initial tumor-specific properties (36).…”
Section: Discussionmentioning
confidence: 99%
“…It has also been suggested that CD24 could be considered as a marker for nasopharyngeal CSCs, since CD24 + cells from NPC cell lines expressed SC genes and were highly proliferative, tumorigenic, and drug resistant [71]. The other introduced molecule for NPC-SCs is ALDH1, because cells with ALDH1 activity expressed pluripotent markers and presented great proliferation, differentiation, migration, and tumorigenic abilities [65,72,73]. Moreover, clinical studies indicated that ALDH1 expression was associated with aggressive tumor behavior and poor survival of NPC [74].…”
Section: Pharynxmentioning
confidence: 98%